During your consultation session, you can discuss your weight loss goals, medical history, and any health concerns
Polycystic ovary syndrome (PCOS) creates insulin resistance and hormonal imbalances that may require additional interventions beyond GLP-1 agonists
Persistent symptoms may indicate an underlying issue that needs medical attention
Given the uncertainties outlined above, speaking to a GP or pharmacist before combining NAD+ supplements with retatrutide or any GLP-1-based therapy is strongly advisable
Understanding Semaglutide for Weight Loss Semaglutide (brand names Wegovy and Ozempic) is a GLP-1 receptor agonist originally developed to treat type 2 diabetes
Type 2 diabetesthe most common indication for GLP-1 therapyis independently associated with a two- to threefold increased risk of ED due to neuropathy, endothelial dysfunction, and reduced nitric oxide availability